Use of specific N-methyl-D-aspartate receptor antagonists in the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514410, A61K 3144, A61K 3140

Patent

active

048883476

ABSTRACT:
Specific N-methyl-D-aspartate receptor antagonists are useful in the prevention and treatment of neurodegeneration in various pathological states.

REFERENCES:
patent: 4064139 (1977-12-01), Anderson et al.
patent: 4374838 (1983-02-01), Anderson et al.
patent: 4399141 (1983-08-01), Anderson et al.
patent: 4657899 (1987-04-01), Rzeszotarski et al.
Goodman and Gillman, The Pharmacological Basis of Therapeutics, 5th ed. (1975) pp. 201-211 and 220-221.
The Lancet, pp. 140-143 (1985) Schwarcz et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of specific N-methyl-D-aspartate receptor antagonists in the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of specific N-methyl-D-aspartate receptor antagonists in the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of specific N-methyl-D-aspartate receptor antagonists in the will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1903101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.